CCCL [China Ceramics] F-3/A: Pre-effective Amendment No. 3 to FORM F-3 REGISTRATION

[Pre-effective Amendment No. 3 to FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 China Ceramics Co., Ltd. ( ) British Virgin Islands (Jurisdiction of Incorporation) Not applicable (I.R.S. Employer Identification Number) c/o Jinjiang Hengda Ceramics Co., Ltd. Junbing Industrial Zone, Anhai, Jinjiang City, Fujian Province, PRC Tel: +86 (595) 8576 5053; Fax: +86 (595) 8576 5059 Huang Jia] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Pre-effective Amendment No. 3 to the Registration Statement (Number 333-206516) on Form F-3 of our report dated April 20, 2015, relating to the consolidated financial statements of China Ceramics Co., Ltd. and its subsidiaries (collectively the “Company”), which appears in the Annual Report]

By | 2016-03-14T20:03:46+00:00 October 9th, 2015|Categories: CCCL, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

OSN [Ossen Innovation] 20-F/A: (Original Filing)

[OSSEN INNOVATION CO., LTD. FORM 20-F ANNUAL REPORT EXPLANATORY NOTE · Subsection (a) of Item 15. · The last 2 paragraphs of subsection (b) of Item 15. ·] [List of Subsidiaries of Ossen Innovation Co. Ltd. Name Country of Incorporation Ossen Innovation Materials Group Co., Ltd. British Virgin Islands Ossen Group (Asia) Co., Ltd. British Virgin Islands Topchina Development Group Ltd. British Virgin Islands Ossen Innovation Materials Co. Ltd. People’s Republic of China Ossen (Jiujiang) New Materials Co., Ltd. People’s Republic of China] [EXCHANGE ACT RULE 13A-14(A)/15D-14(A) OF THE SARBANES-OXLEY ACT OF 2002 I, Wei Hua, certify that: 1. I have reviewed this annual report on Form 20-F/A of Ossen Innovation Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [EXCHANGE ACT RULE 13A-14(A)/15D-14(A) OF THE SARBANES-OXLEY ACT OF 2002 I, Feng Peng, certify that: 1. I have reviewed this annual report on Form 20-F/A of Ossen Innovation Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [1. 2. 9, 2015 Wei Hua] [1. 2. 9, 2015 Feng Peng (Principal Financial Officer)]

By | 2016-03-23T12:13:06+00:00 October 9th, 2015|Categories: Chinese Stocks, OSN, SEC Original|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] CORRESP: (Original Filing)

[787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 VIA EDGAR October 9, 2015 100 F Street, N.E. Attn: David L. Orlic, Special Counsel Office of Mergers and Acquisitions Re: WuXi PharmaTech (Cayman) Inc. Amendment No. 1 to Schedule 13E-3 By WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Holdings Limited, New WuXi Life]

By | 2016-03-24T01:54:56+00:00 October 9th, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] CORRESP: 787 Seventh Avenue New York, NY 10019-6099 Tel:

[787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 VIA EDGAR October 9, 2015 100 F Street, N.E. Attn: David L. Orlic, Special Counsel Office of Mergers and Acquisitions Re: WuXi PharmaTech (Cayman) Inc. Amendment No. 1 to Schedule 13E-3 By WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Holdings Limited, New WuXi Life]

By | 2016-03-24T01:56:08+00:00 October 9th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13E3/A: (Original Filing)

[PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ], 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), to be] []

By | 2016-03-24T01:57:25+00:00 October 9th, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

BABA [Alibaba] 6-K: (Original Filing)

[Voting Results of 2015 Annual General Meeting At Alibaba Group Holding Limited’s (the “Company”) annual general meeting of shareholders held on October 8, 2015 (the “AGM”), the Company’s shareholders elected each of Joseph C. Tsai, Jonathan Zhaoxi Lu, J. Michael Evans and Börje E. Ekholm as a Group I director to serve until the Company’s 2018 annual general meeting, and] [2 ALIBABA GROUP HOLDING LIMITED]

By | 2016-03-17T19:02:10+00:00 October 9th, 2015|Categories: BABA, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13E3/A: PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ],

[PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ], 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), to be] []

By | 2016-03-24T01:58:44+00:00 October 9th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More
Skip to toolbar